Interventions for the management of obesity in people with bipolar disorder-Reference-Cited by-同舟云学术

Interventions for the management of obesity in people with bipolar disorder

Published:2020-07-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tully Agnes¹,Smyth Siobhan¹,Conway Yvonne¹,Geddes John²,Devane Declan¹,Kelly John P³,Jordan Fionnuala¹

Affiliation:

1. School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland

2. Department of Psychiatry; University of Oxford; Oxford UK

3. Pharmacology and Therapeutics; National University of Ireland Galway; Galway Ireland

Publisher

Wiley

Subject

Pharmacology (medical)

Reference104 articles.

1. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial;Alvarez-Jiménez;Journal of Clinical Psychiatry,2006

2. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial;Baptista;Schizophrenia Research,2007

3. Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes;Bartels;American Journal of Psychiatry,2015

4. Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression;Bobo;Annals of Clinical Psychiatry,2011

5. Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trial;Dauphinais;Psychopharmacology Bulletin,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant Weight Gain With the Administration of Lurasidone and Valproic Acid in Schizophrenia and Bipolar Disorder Patients;Cureus;2023-11-18

2. Prevalencia de factores de riesgo cardiovascular en pacientes con trastorno mental de un centro psiquiátrico;Cuaderno de investigaciones: semilleros andina;2023-10-31

3. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers;Expert Review of Clinical Pharmacology;2023-09-28

4. Neighbourhood deprivation and type 2 diabetes in patients with bipolar disorder: A nationwide follow‐up study;Stress and Health;2023-08-10

5. Self-management interventions for adults living with obesity to improve patient-relevant outcomes: An evidence map;Patient Education and Counseling;2023-05